Join us for National Cancer Survivors Day 2016!

Host your own Coffee Party with a Purpose!

Upcoming webinar on May 5:

CADTH - Why does is it important, and what now?

Get involved at your local hospital:

Join a Hospital Patient & Family Advisory Council!

Stay up to date with the latest news and events.

Follow us on Twitter!

Oncology Roundtable:

Establishing a collective vision and set of principles for a national pharmacare strategy

Latest News


  • 5 May

    Register now for CCSN's May 5 webinar on the 2016 CADTH Symposium

    Webinar Information Tune in from 1-2pm EDT on Thursday, May 5. This webinar will feature a round table discussion focusing on the 2016 CADTH Symposium and all the important take-aways for patients & survivors. Featured guests include: - Louise Binder,…

  • 8 May

    Canadian Centre for Applied Research in Cancer Control (ARCC) Conference 2016

    Registration Information 2016 ARCC Conference Canada’s Applied Research in Cancer Control Conference May 8-9, 2016 Hilton Toronto 145 Richmond Street West Toronto, Ontario M5H 2L24 Hilton Toronto Map data ©2016 Google Terms of Use The Canadian Centre for Applied Research…

  • 8 May

    World Ovarian Cancer Day 2016

    Ovarian cancer has the lowest survival rate of all gynecologic cancers, and is characterized around the world by a lack of awareness of symptoms and late stage diagnosis. May 8th, 2013, was the first World Ovarian Cancer Day. On this…

  • 13 May

    ​I​ntegrative Health Institute (IHI)​ Inaugural Conference: Contemporary Insights for Optimizing Health

    Save the Date: M ​ay 13, 2016 Details ​When: ​ Friday, May 13, 2016 ​ ( 8:00 am - 5:00 pm ​)​ Where: University of Alberta (detailed information about location will be sent to all registrants in April) Registration ​…

  • 14 May

    3rd Annual Spotlight on Gastric Cancer

    The Spotlight on Gastric Cancer is a great opportunity for those in the stomach cancer community, the medical community, and the general public to come together to learn more about gastric cancer and connect with others impacted by this disease.…

  • 16 May

    Childhood Cancer Action Day 2016

    REGISTRATION REMINDER! CHILDHOOD CANCER ACTION DAYS WASHINGTON, D.C. Join Us in DC on May 16-17! There's still time to make plans to join the American Childhood Cancer Organization and the Alliance for Childhood Cancer for the 5th Annual Childhood Cancer…

Stay informed

Read our most recent eletter


CCSN is looking for volunteer treasurer! Click here to apply

pCODR is recruiting 1 oncologist to be an Expert Review Committee Member. Click here to learn more.

Get involved at your local hospital by joining a Hospital Patient & Family Advisory Council. Click here to find one in your area!

Nomination for Regional Wellness Councils in NWT. Click here for nomination forms

Submit your comments to Health Canada and the FDA ahead of their public consultation on pharmaceutical regulatory disharmony between Canada and the United States. Click here to learn more.

Have you experienced delays waiting for take-home cancer drugs? Have you experienced issues at your pharmacy or outside of the cancer system? Share your story with CanCertainty.

Take part in this study on prostate cancer: click here to find out how.

Join the Toronto Central Local Health Integration Network’s Citizens’ Panel!

Get involved in a research study focusing on your experience with breast cancer – Click here to find out how.

New Pilot Initiative: Increasing Opportunities for Clinician Input and Feedback in CADTH pan-Canadian Oncology Drug Review Process

Would you like to be nominated to sit on cancer and other healthcare boards? Volunteer for CCSN’s A Seat at the Table!

Are you a female between the ages on 30-56 with a BRCA gene mutation? Click here to learn about this research study!

From our blog

Transparent Public Pricing for Biosimilars: pCPA Releases First Principles for SEBs

April 25 2016

Guest Blog By Arvind ManiDirector of Market Access and Policy ResearchPDCI Market AccessThe pan-Canadian Pharmaceutical Alliance (pCPA) recently issued a communiqué outlining their initial perspective on subsequent entry biologics (SEBs)… Read more of Transparent Public Pricing for Biosimilars: pCPA Releases First Principles for SEBs

  • Janssen
  • Eisai
  • Acart Communications
  • Amgen Canada
  • Brazeau Seller LLP
  • Merck Canada
  • Astellas Oncology
  • Novartis
  • Boehringer Ingelheim
  • EnergiPR
  • Rx&D
  • CannTrust
  • Eli Lilly Oncology
  • Phirelight